SK3 Group's Berkeley Bio Organic Research Laboratories has developed 'Alzatrex' (TM), an herbal supplement that may be taken orally that combines medical cannabis with a proprietary formula of herbal COX-2 inhibitors. Research has shown that 9-THC, the main active ingredient in medical marijuana, decreases -amyloid plaques and neurodegeneration in Alzheimer's disease, and that it is reduced further by the addition of a COX-2 inhibitor. A COX-2 inhibitor is a form of NSAID that is used to reduce pain.

The combination of a COX-2 inhibitor with medical cannabis also prevents marijuana-induced memory problems and 'brain fog' or 'haze' that is common.